We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
HUTCHMED
HCM
$1.93B
| $221K | ﹤0.01% |
6,300
| – | – |
|
1902
The RealReal
REAL
$1.41B
| $221K | ﹤0.01% |
+19,070
| New | +$251K |
|
|
VIRX
1903
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $221K | ﹤0.01% |
+60,515
| New | +$323K |
|
1904
Marten Transport
MRTN
$1.27B
| $220K | ﹤0.01% |
12,800
| – | – |
|
1905
Anika Therapeutics
ANIK
$203M
| $219K | ﹤0.01% |
6,100
-9,700
| -61% | -$388K |
|
1906
Workhorse Group
WKHS
$30.3M
| $219K | ﹤0.01% |
+17
| New | +$309K |
|
1907
OptimizeRx
OPRX
$120M
| $217K | ﹤0.01% |
+3,500
| New | +$265K |
|
|
RVNC
1908
DELISTED
Revance Therapeutics, Inc.
RVNC
| $216K | ﹤0.01% |
+13,230
| New | +$221K |
|
|
OLPX
1909
DELISTED
Olaplex Holdings
OLPX
| $215K | ﹤0.01% |
+7,366
| New | +$195K |
|
|
NARI
1910
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $215K | ﹤0.01% |
+2,360
| New | +$202K |
|
1911
Dime Commercial Bancshares
DCOM
$1.81B
| $214K | ﹤0.01% |
6,100
| – | – |
|
1912
Perdoceo Education
PRDO
$2.07B
| $213K | ﹤0.01% |
18,120
-38,580
| -68% | -$421K |
|
|
EAR
1913
DELISTED
Eargo, Inc. Common Stock
EAR
| $212K | ﹤0.01% |
+2,041
| New | +$265K |
|
|
ZGNX
1914
DELISTED
Zogenix, Inc.
ZGNX
| $212K | ﹤0.01% |
+13,040
| New | +$191K |
|
1915
CEVA Inc
CEVA
$917M
| $210K | ﹤0.01% |
4,861
-17,690
| -78% | -$790K |
|
1916
MacroGenics
MGNX
$242M
| $208K | ﹤0.01% |
+12,980
| New | +$244K |
|
1917
JFrog
FROG
$9.44B
| $207K | ﹤0.01% |
+6,960
| New | +$229K |
|
1918
FuboTV Inc
FUBO
$265M
| $205K | ﹤0.01% |
+1,099
| New | +$309K |
|
1919
Newmark Group
NMRK
$2.89B
| $205K | ﹤0.01% |
+10,960
| New | +$175K |
|
|
PR
1920
Permian Resources
PR
$16.6B
| $205K | ﹤0.01% |
+34,300
| New | +$234K |
|
1921
AtriCure
ATRC
$1.93B
| $203K | ﹤0.01% |
+2,920
| New | +$212K |
|
|
ONL
1922
Orion Office REIT
ONL
$149M
| $203K | ﹤0.01% |
+10,870
| New | +$215K |
|
|
ONEM
1923
DELISTED
1Life Healthcare
ONEM
| $202K | ﹤0.01% |
+11,470
| New | +$222K |
|
1924
HCI Group
HCI
$2.3B
| $200K | ﹤0.01% |
2,400
| – | – |
|
|
ONCR
1925
DELISTED
Oncorus, Inc.
ONCR
| $200K | ﹤0.01% |
38,000
-37,000
| -49% | -$286K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.